EI installs largest SGI UV 300 supercomputer for life sciences worldwide
11 May 2016
The Earlham Institute (EI) partners with Global HPC hardware giant SGI to address the most complex problems in genomics analysis.
With the world’s largest SGI® UV™ 300 installation for Life Sciences and one of the largest Intel® SSD for PCIe*deployments worldwide, EI’s new supercomputing platform gives the research Institute access to the next-generation of SGI UV technology for genomics. This will enable EI researchers to store, categorise and analyse more genomic data in less time for decoding living systems and answering crucial biological questions.
This new EI platform comprises two SGI UV 300 systems totalling 24 terabytes (TB) of shared-memory, 512 Intel® Xeon® Processor E7 v3 cores and 64TB of Intel® P3700 SSDs with NVMe* storage technology. Each SGI UV 300 flash memory solution features 12TB of shared memory with 7th generation SGI NUMAlink® ASIC technology, scaling up to 64 TB of
Paired with flash storage, the combined 24TB SGI UV 300 supercomputers can increase processing speeds of heavy workloads in scientific research by 80 percent. This combination of leading-edge technology allows EI researchers to benefit from the faster processing capabilities of the SGI UV 300, providing an extraordinarily powerful platform for genomics analysis.
In particular, the system will dramatically reduce the time to perform large genome assembly that EI researchers specialise in, as well as the analysis of wheat genotype and phenotype data generated by the Seeds of Discovery programme. EI will use the pioneering SGI HPC technology to enable faster analysis of complex genomes which require both large memory and fast processing capabilities, providing a powerful boost to EI’s research projects. This will include sequencing and
The new technology will also be used to aid the development of novel analysis techniques for data integration, by taking advantage of the larger, faster memory-per-core specifications of the system and its accelerated I/O capabilities from the NVMe SSDs. This will provide a significant speedup of data movement between the hardware and EI’s genome analysis software.
Dr Tim Stitt, Head of Scientific Computing at EI, said: “Continuing our successful collaborations with SGI and Intel in deploying novel and innovative computing technology, the new SGI UV 300 appliance with NVMe SSDs will undoubtedly be a leader in-field of genomic analysis.
“With the unique shared-memory technology from SGI and Intel’s leading processor and non-volatile memory storage solutions, this system will set the new yardstick for large-scale data-intensive bioinformatics computations. The combination of processor performance, memory capacity and one of the largest deployments of Intel SSD storage worldwide makes this a truly powerful computing platform for the life sciences.”
Jorge Titinger, president and CEO, SGI, said: “The complexity of genomic data and workloads today requires high performance computing (HPC) to provide new insights for researchers and allow them to derive conclusions from the massive data jigsaw puzzle. This enables EI to tackle fundamental problems such as increasing the yield of crops to keep up with the population growth. SGI is honoured to be extending the partnership with EI by providing the SGI UV 300 architecture. This system is designed for data intensive, in-memory, I/O demanding applications and includes the very latest NUMAlink 7 ASIC, scaling right up to 64TB of globally addressable memory as a single system. This is all done using Open Standards unmodified Linux allowing for the SGI UV to be run as one system, offering flexibility for exploring new algorithms and programming models without restriction.
“By tightly coupling the Intel® P3700 SSDs with NVMe* storage technology with the latest generation SGI UV 300 system, SGI allows customers like EI to achieve extraordinary bandwidth and inputs/outputs per second (IOPS) and will keep EI research and productivity at the very top of this highly competitive worldwide domain of genomic analysis. We are very proud of such a successful collaboration and look forward to EI researchers
Part of the SGI UV server line for
The SGI UV server, in its fifth generation, is well placed to serve this need. For EI, a key benefit for using this most powerful system is the scalability and memory capabilities to execute some of the most demanding data and compute-intensive workloads including large,
EI is strategically funded by BBSRC and operates a National Capability to promote the application of genomics and bioinformatics to advance bioscience research and innovation.
Notes to editors
Notes to Editors
1)The crop yield monitoring devices and services market has rapidly expanded in recent years. MarketsandMarket expects it to reach $2.51 billion by 2020, with a compound annual growth rate of 7.17% between 2014 and 2020.
2) Following a thorough research and development phase, we anticipate being able to deliver a product at significantly cheaper than current market solutions - existing large-scale phenotyping solutions retail in the region of £300,000.
For more information, please contact:
Marketing & Communications Officer, Earlham Institute (EI)
- +44 (0)1603 450 107
The Earlham Institute (EI) is a world-leading research institute focusing on the development of genomics and computational biology. EI is based within the Norwich Research Park and is one of eight institutes that receive strategic funding from Biotechnology and Biological Science Research Council (BBSRC) - £6.45M in 2015/2016 - as well as support from other research funders. EI operates a National Capability to promote the application of genomics and bioinformatics to advance bioscience research and innovation.
EI offers a state of the art DNA sequencing facility, unique by its operation of multiple complementary technologies for data generation. The Institute is a UK hub for innovative bioinformatics through research, analysis and interpretation of multiple, complex data sets. It hosts one of the largest computing hardware facilities dedicated to life science research in Europe. It is also actively involved in developing novel platforms to provide access to computational tools and processing capacity for multiple academic and industrial users and promoting applications of computational Bioscience. Additionally, the Institute offers a training programme through courses and workshops, and an outreach programme targeting key stakeholders, and wider public audiences through dialogue and science communication activities.
The Biotechnology and Biological Sciences Research Council (BBSRC) invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.
Funded by Government, BBSRC invested over £509M in world-class bioscience in 2014-15 and is the leading funder of wheat research in the UK (over £100M investment on UK wheat research in the last 10 years). We support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.
SGI is a global leader in high-performance solutions for compute, data analytics and data management that enable customers to accelerate time to discovery, innovation, and profitability. Visit sgi.com for more information.
Grayling Public Relations I Alan Auyeung | (415) 593-1400
SGI Investor Relations | Ben Liao | (669) 900-8090 | email@example.com
© 2016 Silicon Graphics International Corp. All rights reserved. SGI, the SGI logo, SGI UV and NUMAlink are trademarks or registered trademarks of Silicon Graphics International Corp. or its subsidiaries in the United States and/or other countries. Intel and Xeon are trademarks of Intel Corporation in the U.S. and/or other countries.
*Other names and brands may be claimed as the property of others.